These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28035989)

  • 81. Generation of Orthotopic and Subcutaneous Patient-Derived Xenograft Models from Diverse Clinical Tissue Samples of Pediatric Extracranial Solid Tumors.
    Hanssen KM; Fletcher JI; Kamili A
    Methods Mol Biol; 2024; 2806():55-74. PubMed ID: 38676796
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.
    Van Maerken T; Sarkar D; Speleman F; Dent P; Weiss WA; Fisher PB
    J Cell Physiol; 2009 Jun; 219(3):707-15. PubMed ID: 19202553
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
    Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
    Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neuroblastoma in Children Under 12 Months in Singapore--15-Year Experience and Outcomes From KKH.
    Koh V; Soh SY; Chan MY; Tan AM
    Fetal Pediatr Pathol; 2015 Jun; 34(3):155-61. PubMed ID: 25616021
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.
    Brady SW; Liu Y; Ma X; Gout AM; Hagiwara K; Zhou X; Wang J; Macias M; Chen X; Easton J; Mulder HL; Rusch M; Wang L; Nakitandwe J; Lei S; Davis EM; Naranjo A; Cheng C; Maris JM; Downing JR; Cheung NV; Hogarty MD; Dyer MA; Zhang J
    Nat Commun; 2020 Oct; 11(1):5183. PubMed ID: 33056981
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.
    Morandi F; Frassoni F; Ponzoni M; Brignole C
    J Immunol Res; 2018; 2018():8097398. PubMed ID: 30510968
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular pathogenesis of peripheral neuroblastic tumors.
    Janoueix-Lerosey I; Schleiermacher G; Delattre O
    Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology.
    Wienke J; Dierselhuis MP; Tytgat GAM; Künkele A; Nierkens S; Molenaar JJ
    Eur J Cancer; 2021 Feb; 144():123-150. PubMed ID: 33341446
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo.
    Yan S; Li Z; Thiele CJ
    Oncotarget; 2013 Mar; 4(3):433-45. PubMed ID: 23531921
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
    Maggio V; Chierici M; Jurman G; Furlanello C
    PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mechanisms of invasion and metastasis in human neuroblastoma.
    Ara T; DeClerck YA
    Cancer Metastasis Rev; 2006 Dec; 25(4):645-57. PubMed ID: 17160711
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Neuroblastoma, retinoblastoma, and brain tumors in children.
    Brodeur GM; Saylors RL
    Curr Opin Oncol; 1991 Jun; 3(3):485-96. PubMed ID: 1892917
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.
    Curtin C; Nolan JC; Conlon R; Deneweth L; Gallagher C; Tan YJ; Cavanagh BL; Asraf AZ; Harvey H; Miller-Delaney S; Shohet J; Bray I; O'Brien FJ; Stallings RL; Piskareva O
    Acta Biomater; 2018 Apr; 70():84-97. PubMed ID: 29447961
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
    Sholler GLS; Bergendahl G; Lewis EC; Kraveka J; Ferguson W; Nagulapally AB; Dykema K; Brown VI; Isakoff MS; Junewick J; Mitchell D; Rawwas J; Roberts W; Eslin D; Oesterheld J; Wada RK; Pastakia D; Harrod V; Ginn K; Saab R; Bielamowicz K; Glover J; Chang E; Hanna GK; Enriquez D; Izatt T; Halperin RF; Moore A; Byron SA; Hendricks WPD; Trent JM
    Genome Med; 2024 Feb; 16(1):28. PubMed ID: 38347552
    [TBL] [Abstract][Full Text] [Related]  

  • 96. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
    Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
    RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
    Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
    Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
    Liang WH; Federico SM; London WB; Naranjo A; Irwin MS; Volchenboum SL; Cohn SL
    JCO Clin Cancer Inform; 2020 Oct; 4():895-905. PubMed ID: 33058692
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recent advances in the developmental origin of neuroblastoma: an overview.
    Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
    J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma.
    Dahlhaus M; Burkovski A; Hertwig F; Mussel C; Volland R; Fischer M; Debatin KM; Kestler HA; Beltinger C
    Cancer Lett; 2016 Feb; 371(1):79-89. PubMed ID: 26616283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.